Trial intelligence / Profile preview

Methylphenidate response in cocaine-dependent ADHD patients: DAT SPECT study

2009-012261-61Phase 3Active

Sponsor
Academic Medical Center
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Primary. Started May 2009; status: active.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2009-012261-61.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012261-61.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call